Anton Ussi (MSc) is chief executive officer at EATRIS ERIC, the ESFRI European infrastructure for translational medicine. Joining EATRIS in 2010, he was part of the team responsible for the design and statutory incorporation of the infrastructure, whose mission it is to improve the translation of academic innovations into high impact health interventions. In his current role as CEO since 2015, Ussi has a background in technology transfer, with previous history in mechanical engineering and automotive design, and small business administration. Ussi is also Principal Investigator of REMEDi4ALL, a large multi-sector EU- and UK-funded initiative comprising 26 partners. The REMEDi4ALL mission is to deliver functioning pan-European medicines repurposing eco-system covering all development phases and market entry.
